Maria-Cruz Morillo – Biography
Last update: April 12, 2026Executive profile
Maria-Cruz Morillo joined Neuland in 2022. Maria-Cruz served as Executive Director, Global Therapeutic Operations Lead, Rare Disease and Global Operations Head, Global Project Leadership, Rare Diseases for Neuland.
Maria-Cruz Morillo is currentlyHead of Advanced Therapies, Cell and Gene Therapies & Rare Disease at Allucent - View - Allucent org chart
Create your alert
to follow the career of Maria-Cruz Morillo.
Education
Maria-Cruz Morillo has a Master in Research and Development of New Drug from Universidad de Navarra.
More about Maria-Cruz Morillo
Do you need to know more about Maria-Cruz Morillo? More results.
Participate
Social media
- Maria-Cruz Morillo on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Maria-Cruz Morillo
The colleagues of Maria-Cruz Morillo
Company Colleagues
- At Allucent, Maria-Cruz Morillo has 21 colleagues including Paula Brown (CEO), Mark Goldberg (Chairman of the Board)…
Industry Colleagues
- In the Healthcare industry, Maria-Cruz Morillo has 54,708 colleagues in 3,502 companies located in 59 countries. 39,527 executive movements have been recorded in the last 12 months. Learn more about Healthcare.
Report an error
Update the org chart details of Maria-Cruz Morillo.
Get in Touch
Here are a few tips for establishing great contacts.
